Table 1 Summary table listing the clinical studies with tocotrienols in cardiovascular diseases during the period of 1991–2011
S/N | Journal title | References |
|---|---|---|
1 | Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee) | Qureshi A.A. et al. (1991). American Journal of Clinical Nutrition. [79] |
2 | Effect of a palm-oil--vitamin E concentrate on the serum and lipoprotein lipids in humans1,3 | Tan D.T.S. et al. (1991). American Journal of Clinical Nutrition. [17] |
3 | Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolaemic individuals without change in coronary risk factors | Wahlqvist M.L. et al. (1992). Nutr Res. [84] |
4 | Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis | Tomeo A.C. et al. (1995). Lipids. |
5 | Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. | Qureshi A.A. et al. (1997). The Journal of Nutritional Biochemistry. |
6 | Synergistic effect of tocotrienol-rich fraction (TRF25) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans | Qureshi A.A. et al. (2001). Journal of Nutritional Biochemistry [79] |
7 | Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans | Qureshi A.A. et al. (2002). Atherosclerosis. |
8 | Dose Dependent Elevation of Plasma Tocotrienol Levels and Its Effect on Aterial Compliance, Plasma Total Antioxidant Status, and Lipid Profile in Healthy Humans Supplemented with Tocotrienols Rich Vitamin E | Rasool A.H.G. et al. (2006) Journal of Nutritional Science and Vitaminology. |
9 | Gamma Delta Tocotrienols Reduce Hepatic Triglyceride Synthesis and VLDL Secretion | Zaiden N. et al. (2010). Journal of Atherosclerosis and Thrombosis. |
10 | Effect of Mixed-Tocotrienols in Hypercholesterolemic Subjects | Yuen K.H. et al. (2011). Functional Foods in Health and Disease. [96] |